z-logo
open-access-imgOpen Access
Roscovitine synergizes with conventional chemo-therapeutic drugs to induce efficient apoptosis of human colorectal cancer cells
Author(s) -
Mohamed-Salah I. Abaza,
Abdul-Majeed Bahman,
Rajaa AlAttiyah
Publication year - 2008
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.14.5162
Subject(s) - apoptosis , doxorubicin , cell cycle , colorectal cancer , biology , pharmacology , cancer , chemotherapy , biochemistry , genetics
To examine the ability of cyclin-dependent kinase inhibitor (CDKI) roscovitine (Rosco) to enhance the antitumor effects of conventional chemotherapeutic agents acting by different mechanisms against human colorectal cancer.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here